Search Orphan Drug Designations and Approvals
-
Generic Name: | 3-(4-(1,5-Napthrydine)-Imidazole[1,2-a]pyridine-7-(1-phenyl-4-(1-(4-methyl piperazine) |
---|---|
Date Designated: | 07/14/2015 |
Orphan Designation: | Treatment of fibrodysplasia ossificans progressiva. |
Orphan Designation Status: | Designated/Designation Withdrawn or Revoked |
Date Designation Withdrawn or Revoked: | 06/26/2019 |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
La Jolla Pharmaceutical Company, Inc. 10182 Telesis Court Suite 600 San Diego, California 92121 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-